1-Hydroxybenzotriazole → HCID 71287832, compound
Reaction equation
[C:1]1([N:7]2[C:11]([C:12]3[CH:17]=[CH:16][CH:15]=[C:14]([CH2:18][CH2:19][CH3:20])[CH:13]=3)=[CH:10][C:9]([NH2:21])=[N:8]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[O:22]=[C:23]1[NH:28][CH2:27][CH:26]([C:29](O)=[O:30])[CH2:25][CH2:24]1.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.C(=O)([O-])O.[Na+]>O1CCCC1.O>[C:1]1([N:7]2[C:11]([C:12]3[CH:17]=[CH:16][CH:15]=[C:14]([CH2:18][CH2:19][CH3:20])[CH:13]=3)=[CH:10][C:9]([NH:21][C:29]([CH:26]3[CH2:25][CH2:24][C:23](=[O:22])[NH:28][CH2:27]3)=[O:30])=[N:8]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 1-phenyl-5-(3-propylphenyl)-1H-pyrazol-3-ylamine (56 mg) in tetrahydrofuran (1.5 ml) were sequentially added an optically active compound of 6-oxopiperidine-3-carboxylic acid (43 mg) synthesized in Preparation 7 (derived from the low-polarity component of 5-((R)-4-benzyl-2-oxoxazolidine-3-carbonyl)-1-(2,4-dimethoxybenzyl)piperidin-2-one), HOBt.H2O (46 mg) and WSC.HCl (58 mg), and the mixture was stirred at room temperature overnight. To this reaction solution was added a saturated aqueous solution of sodium hydrogen carbonate, and the mixture was extracted with ethyl acetate. The separated organic layer was concentrated under reduced pressure, the resulting residue was purified by silica gel thin-layer chromatography (eluent: chloroform/methanol=10/1) to give the titled compound (50 mg).
Workup
- customsynthesized in Preparation 7 (
- extractionthe mixture was extracted with ethyl acetate
- concentrationThe separated organic layer was concentrated under reduced pressure
- customthe resulting residue was purified by silica gel thin-layer chromatography (eluent: chloroform/methanol=10/1)
Sources & evidence
- ORD record
- ord-6003fbbf4e7d48478a365bde9ed191ca
- Source dataset
- uspto-grants-2014_09
- Patent number
- US08846746B2
Reaction notes
Loading…